EDGAR Filing Documents for 0001213900-22-055768

Form 8-K - Current report:

SEC Accession No. 0001213900-22-055768

Filing Date

2022-09-14

Accepted

2022-09-13 21:59:15

Documents

Period of Report

2022-09-09

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea165740-8k_inmedpharma.htm iXBRL	8-K	43664
2	FORM OF PRE-FUNDED WARRANT	ea165740ex4-1_inmedpharma.htm	EX-4.1	100068
3	FORM OF PREFERRED INVESTMENT OPTION	ea165740ex4-2_inmedpharma.htm	EX-4.2	104699
4	FORM OF PLACEMENT AGENT PREFERRED INVESTMENT OPTION	ea165740ex4-3_inmedpharma.htm	EX-4.3	105078
5	FORM OF SECURITIES PURCHASE AGREEMENT	ea165740ex10-1_inmedpharma.htm	EX-10.1	226465
6	FORM OF REGISTRATION RIGHTS AGREEMENT	ea165740ex10-2_inmedpharma.htm	EX-10.2	134613
7	PRESS RELEASE DATED SEPTEMBER 9, 2022	ea165740ex99-1_inmedpharma.htm	EX-99.1	12744
8	PRESS RELEASE DATED SEPTEMBER 13, 2022	ea165740ex99-2_inmedpharma.htm	EX-99.2	12518
9	GRAPHIC	ex99-1_001.jpg	GRAPHIC	5094
10	GRAPHIC	ex99-2_001.jpg	GRAPHIC	5094
	Complete submission text file	0001213900-22-055768.txt		1112524

Data Files

Seq	Description	Document	Type	Size
11	XBRL SCHEMA FILE	inm-20220909.xsd	EX-101.SCH	3230
12	XBRL LABEL FILE	inm-20220909_lab.xml	EX-101.LAB	34240
13	XBRL PRESENTATION FILE	inm-20220909_pre.xml	EX-101.PRE	22362
15	EXTRACTED XBRL INSTANCE DOCUMENT	ea165740-8k_inmedpharma_htm.xml	XML	3627

Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4

Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207

InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)